Alamar Biosciences, Inc. (California) (ALMR)
30.49
+1.13
(+3.85%)
USD |
NASDAQ |
Sep 02, 16:00
30.49
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Cash from Investing (Quarterly) : -120.80M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -120.80M |
| March 31, 2026 | -0.778M |
| Date | Value |
|---|---|
| June 30, 2025 | 17.94M |
| March 31, 2025 | 17.02M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| 10X Genomics, Inc. | -7.735M |
| Personalis, Inc. | 38.16M |
| Twist Bioscience Corp. | -10.20M |
| Adaptive Biotechnologies Corp. | -43.48M |
| Champions Oncology, Inc. | -0.238M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.32M |
| Cash from Financing (Quarterly) | 201.84M |
| Free Cash Flow | -63.24M |
| Free Cash Flow Per Share (Quarterly) | -0.2172 |
| Free Cash Flow to Equity (Quarterly) | 274.07M |
| Free Cash Flow to Firm (Quarterly) | -14.85M |
| Free Cash Flow Yield | -2.99% |